ArticleACS organic & inorganic Au2026
Development of Noval, Recyclable, and Tunable Aryl Imidazolium Salts with a Dual Brønsted-Lewis Acid Character as Catalysts for the Copper(I)-Catalyzed Azide-Alkyne Cycloaddition Reaction (CuAAC).
Article in ACS organic & inorganic Au, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The development of novel aryl imidazolium salts (ISs) with dual Brønsted-Lewis acid character represents a significant advancement in the field of green chemistry and catalysis. These imidazolium salts serve as efficient catalysts for the copper-(I)-catalyzed azide-alkyne cycloaddition (CuAAC) reaction, a cornerstone of click chemistry. The unique design of the aryl imidazolium framework, incorporating both Brønsted and Lewis acid sites, enhances the catalytic efficiency and selectivity of the CuAAC reaction. Furthermore, the use of these imidazolium salts as catalysts eliminates the need for additional phase-transfer catalysts or cosolvents, simplifying the reaction setup and reducing environmental impact. This study demonstrates the synthesis, characterization, and application of these novel imidazolium salts, highlighting their potential as sustainable and efficient media for CuAAC reactions. The developed catalyst is stable in water and air, and the highest catalytic activity could still be maintained after 4 cycles. The results indicate that the novel, recyclable, and tunable aryl imidazolium salts with dual Brønsted-Lewis acid properties offer a promising platform for the development of greener and more efficient catalytic processes in organic synthesis.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.